John Temperato - Nov 18, 2021 Form 4 Insider Report for 9 METERS BIOPHARMA, INC. (NMTR)

Role: Chief Executive Officer, Director
Signature: /s/ Edward J. Sitar, as power of attorney
Stock symbol: NMTR
Transactions as of: Nov 18, 2021
Transactions value $: $52,500
Form type: 4
Date filed: 11/19/2021, 06:31 AM
Previous filing: Aug 19, 2021
Next filing: Feb 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NMTR	Common stock	Purchase	$52.5K	+50K	+4.54%	$1.05	1.15M	Nov 18, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.08, inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Content

The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.08, inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.